reach semaglutide (Wegovy) is associated with a 41% reduction in the risk for major adverse cardiovascular events (MACEs) within 6 months of initiation — well before patients achieve substantial weight loss or Semaglutide Starting Dose & Personalized

Here is the breakdown of the latest research and what it means for your health

When you start semaglutide on day 7 (one week after your last tirzepatide dose), roughly 40% of the tirzepatide remains active

Clinical Diabetes: A Publication of the American Diabetes Association, 37 (3), 227233

That is why at Biohackr Health, we start you at a low dose and move you up

As compounded GLP-1 programs become more widely discussed across the market, and as pricing transparency becomes a key factor for prospective patients, platforms like IVY Rx are drawing attention for their flat-rate monthly structure and direct-to-consumer model